These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32635212)

  • 1. Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular Endothelium.
    Volokhina EB; Feitz WJC; Elders LM; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32635212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin.
    Feitz WJC; van Setten PA; van der Velden TJAM; Licht C; van den Heuvel LPJW; van de Kar NCAJ
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate.
    Geelen J; Valsecchi F; van der Velden T; van den Heuvel L; Monnens L; Morigi M
    Nephrol Dial Transplant; 2008 Oct; 23(10):3091-5. PubMed ID: 18469308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin
    Wijnsma KL; Veissi ST; de Wijs S; van der Velden T; Volokhina EB; Wagener FADTG; van de Kar NCAJ; van den Heuvel LP
    Front Immunol; 2020; 11():547406. PubMed ID: 33414780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
    Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
    J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
    Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
    Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
    Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
    J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
    Siegler RL; Obrig TG; Pysher TJ; Tesh VL; Denkers ND; Taylor FB
    Pediatr Nephrol; 2003 Feb; 18(2):92-6. PubMed ID: 12579394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.
    Betzen C; Plotnicki K; Fathalizadeh F; Pappan K; Fleming T; Bielaszewska M; Karch H; Tönshoff B; Rafat N
    J Infect Dis; 2016 Mar; 213(6):1031-40. PubMed ID: 26582960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
    Locatelli M; Buelli S; Pezzotta A; Corna D; Perico L; Tomasoni S; Rottoli D; Rizzo P; Conti D; Thurman JM; Remuzzi G; Zoja C; Morigi M
    J Am Soc Nephrol; 2014 Aug; 25(8):1786-98. PubMed ID: 24578132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
    Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
    Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1.
    Zoja C; Angioletti S; Donadelli R; Zanchi C; Tomasoni S; Binda E; Imberti B; te Loo M; Monnens L; Remuzzi G; Morigi M
    Kidney Int; 2002 Sep; 62(3):846-56. PubMed ID: 12164866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
    Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
    Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.
    Ritchie JM; Wagner PL; Acheson DW; Waldor MK
    Appl Environ Microbiol; 2003 Feb; 69(2):1059-66. PubMed ID: 12571029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.
    Landoni VI; de Campos-Nebel M; Schierloh P; Calatayud C; Fernandez GC; Ramos MV; Rearte B; Palermo MS; Isturiz MA
    Infect Immun; 2010 Mar; 78(3):1193-201. PubMed ID: 20008539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.